Clinical characteristics of relapses and re-infections in Clostridium difficile infection

Clinical Microbiology and Infection

Volumn 20, Issue 11, 2014, Pages 1198-1204

  Kim, J ^a   Seo, M R ^a   Kang, J O ^a   Kim, Y ^a   Hong, S P ^a   Pai, H ^a  

^a Hanyang University   (South Korea)

Author keywords

Clostridium difficile infection; Multilocus variable number tandem repeat analysis; PCR ribotyping; Re infection; Recurrence; Relapse

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; LAXATIVE; METRONIDAZOLE; MUCOLYTIC AGENT; OPIATE; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; STEROID; VANCOMYCIN; BACTERIAL DNA;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFECTIOUS DIARRHEA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTILOCUS VARIABLE NUMBER TANDEM REPEAT; MULTIPLEX POLYMERASE CHAIN REACTION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT INFECTION; REINFECTION; RELAPSE; RIBOTYPING; RISK FACTOR; VARIABLE NUMBER OF TANDEM REPEAT; VERY ELDERLY; CLOSTRIDIUM INFECTION; DIARRHEA; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR TYPING; PATHOLOGY; POLYMERASE CHAIN REACTION; RECURRENT DISEASE; TIME;

CLOSTRIDIUM DIFFICILE;

AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; DNA, BACTERIAL; FEMALE; GENOTYPE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; RECURRENCE; RIBOTYPING; TIME FACTORS;

EID: 84917670799     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12704     Document Type: Article

References (28)

1. Marsh JW, Arora R, Schlackman JL, Shutt KA, Curry SR, Harrison LH. Association of relapse of Clostridium difficile disease with BI/NAP1/027. J Clin Microbiol 2012; 50: 4078-4082.
2. Barbut F, Richard A, Hamadi K, Chomette V, Burghoffer B, Petit JC. Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol 2000; 38: 2386-2388.
3. Hebert C, Du H, Peterson LR, Robicsek A. Electronic health record-based detection of risk factors for Clostridium difficile infection relapse. Infect Control Hosp Epidemiol 2013; 34: 407-414.
4. Noren T, Akerlund T, Back E et al. Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J Clin Microbiol 2004; 42: 3635-3643.
5. Eyre DW, Walker AS, Griffiths D et al. Clostridium difficile mixed infection and reinfection. J Clin Microbiol 2012; 50: 142-144.
6. Pepin J, Alary ME, Valiquette L et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 2005; 40: 1591-1597.
7. Kim J, Kang JO, Kim H et al. Epidemiology of Clostridium difficile infections in a tertiary-care hospital in Korea. Clin Microbiol Infect 2013; 19: 521-527.
8. Huang H, Fang H, Weintraub A, Nord CE. Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm. Clin Microbiol Infect 2009; 15: 1170-1173.
9. Goorhuis A, Legaria MC, van den Berg RJ et al. Application of multiple-locus variable-number tandem-repeat analysis to determine clonal spread of toxin A-negative Clostridium difficile in a general hospital in Buenos Aires, Argentina. Clin Microbiol Infect 2009; 15: 1080-1086.
10. Collins DA, Hawkey PM, Riley TV. Epidemiology of Clostridium difficile infection in Asia. Antimicrob Resist Infect Control 2013; 2: 21.
11. Goorhuis A, Debast SB, Dutilh JC et al. Type-specific risk factors and outcome in an outbreak with 2 different Clostridium difficile types simultaneously in 1 hospital. Clin Infect Dis 2011; 53: 860-869.
12. Hawkey PM, Marriott C, Liu WE et al. Molecular epidemiology of Clostridium difficile infection in a major Chinese hospital: an underrecognized problem in Asia? J Clin Microbiol 2013; 51: 3308-3313.
13. Bauer MP, Notermans DW, van Benthem BH et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011; 377: 63-73.
14. Kim J, Kang JO, Pai H, Choi TY. Association between PCR ribotypes and antimicrobial susceptibility among Clostridium difficile isolates from healthcare-associated infections in South Korea. Int J Antimicrob Agents 2012; 40: 24-29.
15. Spigaglia P, Barbanti F, Dionisi AM, Mastrantonio P. Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018. J Clin Microbiol 2010; 48: 2892-2896.
16. Kim J, Pai H, Seo MR, Kang JO. Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital. J Korean Med Sci 2011; 26: 1258-1264.
17. Mulvey MR, Boyd DA, Gravel D et al. Hypervirulent Clostridium difficile strains in hospitalized patients, Canada. Emerg Infect Dis 2010; 16: 678-681.
18. Marsh JW, O'Leary MM, Shutt KA et al. Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in hospitals. J Clin Microbiol 2006; 44: 2558-2566.
19. Curry SR, Muto CA, Schlackman JL et al. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis 2013; 57: 1094-1102.
20. Fujitani S, George WL, Murthy AR. Comparison of clinical severity score indices for Clostridium difficile infection. Infect Control Hosp Epidemiol 2011; 32: 220-228.
21. World Health Organisation. The anatomical therapeutic chemical (ATC) and defined daily dosing (DDD) system index 2010. Available from: http://www.whocc.no/. (last accessed 28 October 2010).
22. Persson S, Torpdahl M, Olsen KE. New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection. Clin Microbiol Infect 2008; 14: 1057-1064.
23. Bidet P, Barbut F, Lalande V, Burghoffer B, Petit JC. Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiol Lett 1999; 175: 261-266.
24. Stewart DB, Berg A, Hegarty J. Predicting recurrence of C. difficile colitis using bacterial virulence factors: binary toxin is the key. J Gastrointest Surg 2013; 17: 118-124.
25. Figueroa I, Johnson S, Sambol SP, Goldstein EJ, Citron DM, Gerding DN. Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin. Clin Infect Dis 2012; 55 (suppl): 104-109.
26. O'Connor JR, Johnson S, Gerding DN. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 2009; 136: 1913-1924.
27. Barbut F, Gariazzo B, Bonne L et al. Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004. Infect Control Hosp Epidemiol 2007; 28: 131-139.
28. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007; 28: 140-145.